04 March 2026

Can the brain sense cancer? Up to $25M awarded to a team including the Champalimaud Foundation to explore a new frontier in oncology

Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.

26 February 2026

Champalimaud Foundation and Instituto Superior Técnico Join Forces to Lead Research in Neurorobotics

The Champalimaud Foundation (CF) and Instituto Superior Técnico (IST) have established a five-year strategic partnership to create a Neurorobotics Laboratory within the CF Neurotechnology Warehouse. Signed on 18 February, the agreement brings together two of Portugal’s leading research institutions with the goal of advancing the understanding of intelligence - both biological and artificial - at the convergence of brain science, robotics and artificial intelligence.

11 February 2026

Different Visual Experiences Give Rise to Different Neural Wiring

The visual system is hierarchically organised into different areas. The lower visual areas see small parts of the visual field, and they are sensitive to very simple features, such as edges and their orientation. Higher up the hierarchy, the visual areas start encoding more abstract representations of the world, expanding their visual field to respond to stimuli such as objects and faces.  

10 February 2026

Controlled “Oxidative Spark”: A Surprising Ally in Brain Repair

Oxidative stress is a direct consequence of an excess in the body of so-called “free radicals” – reactive, unstable molecules that contain oxygen. Free radicals are normal metabolic by-products and also help to relay signals in the body. In turn, oxidative stress (an overload of these molecules) can be caused by lifestyle, environmental and biological factors such as smoking, high alcohol consumption, poor diet, stress, pollution, radiation, industrial chemicals, and chronic inflammation.

09 December 2025

Two Life Science Projects in Portugal Awarded with a European Research Council (ERC) Consolidator Grant

Today, the European Research Council (ERC) announced the results of its latest Consolidator Grants call, the second level of this type of funding, for researchers with consolidated work in their fields. Two new life science projects in Portugal secured a combined total of €4.1M. These grants were awarded to Juan Álvaro Gallego, who recently joined the CF, and Ricardo Araújo from Instituto Superior Técnico / Centro de Recursos Naturais e Ambiente (CERENA) .

03 December 2025

Champalimaud Foundation installs powerful MRI scanner, setting new standards in high-field imaging

The Champalimaud Foundation installed a new 18-Tesla horizontal-bore MRI scanner, custom-built in Germany at the Pre-Clinical MRI Lab, a team led by Principal Investigator Noam Shemesh. The system is the strongest horizontal-bore MRI scanner constructed to date and is currently the only one of its kind.

“This is the most powerful system in the world for in-vivo imaging,” says Shemesh. “By combining an exceptionally strong magnetic field with signal-boosting cryogenic coils, this equipment enables capabilities that have not been available before.”

21 November 2025

Albino Oliveira-Maia Elected President of the Portuguese Society of Psychiatry and Mental Health

Albino Oliveira-Maia, psychiatrist, neuroscientist, and Director of the Neuropsychiatry Unit at the Champalimaud Foundation, has been elected to serve as President-Elect for the 2026–2029 term. He will subsequently assume the full presidency of the SPPSM from 2029 to 20321. Upon accepting the position, Oliveira-Maia emphasized the importance of advancing scientific progress and ensuring its real-world impact, stating: “Through leadership of this Society I hope to continue and expand on the work needed to make science and innovation accessible to those that most need it.”

28 November 2025

Pfizer Awards 2025 recognise two researchers from the Champalimaud Foundation

Personalised Medicine for Colorectal Cancer

In the Clinical Research category, the award went to Rita Fior, leader of the Cancer Development and Innate Immune Evasion Group, for the study “The zAvatar test forecasts clinical treatment response in patients with colorectal cancer: a co-clinical study paving the way for personalised medicine.” Bruna Costa, a postdoctoral researcher, is the first author of the recognised work.

26 November 2025

In insects, the evolution of feeding preferences is rooted in the brain, and not only in the peripheral taste sensors, scientists find

24 November 2025

Your gut’s railway switch: how the “second brain” decides between attack and repair

The work fits into a broader effort to understand how the immune system maintains balance – a theme underscored by this year’s Nobel Prize in Physiology or Medicine for discoveries in immune tolerance.

Subscribe to Champalimaud Research
Loading
Please wait...